Cassady Schiller Wealth Management, LLC Catalyst Pharmaceuticals, Inc. Put Options Transaction History
Cassady Schiller Wealth Management, LLC
- $268 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CPRX
# of Institutions
359Shares Held
98.6MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$442 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$199 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$137 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$74 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$71.2 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.43B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...